000 | 01604 a2200433 4500 | ||
---|---|---|---|
005 | 20250513045913.0 | ||
264 | 0 | _c19950321 | |
008 | 199503s 0 0 eng d | ||
022 | _a0085-2538 | ||
024 | 7 |
_a10.1038/ki.1994.380 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGoodman, W G | |
245 | 0 | 0 |
_aDevelopment of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. _h[electronic resource] |
260 |
_bKidney international _cOct 1994 |
||
300 |
_a1160-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aBone Diseases _xetiology |
650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
650 | 0 | 4 |
_aCalcitriol _xadministration & dosage |
650 | 0 | 4 |
_aCalcium _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aChronic Kidney Disease-Mineral and Bone Disorder _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperparathyroidism, Secondary _xblood |
650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
650 | 0 | 4 |
_aOsteitis _xdrug therapy |
650 | 0 | 4 |
_aParathyroid Hormone _xblood |
650 | 0 | 4 |
_aPeritoneal Dialysis _xadverse effects |
650 | 0 | 4 |
_aPhosphorus _xblood |
700 | 1 | _aRamirez, J A | |
700 | 1 | _aBelin, T R | |
700 | 1 | _aChon, Y | |
700 | 1 | _aGales, B | |
700 | 1 | _aSegre, G V | |
700 | 1 | _aSalusky, I B | |
773 | 0 |
_tKidney international _gvol. 46 _gno. 4 _gp. 1160-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ki.1994.380 _zAvailable from publisher's website |
999 |
_c7861048 _d7861048 |